This new US$65 million, 70,000 square foot facility, officially opened on Jun. 23, brings 50 new jobs to the area. BURLINGTON — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, ...
Officials at MilliporeSigma say the company will begin a $65 million expansion of its high potency API (HPAPI) and antibody drug conjugate (ADC) manufacturing capabilities and capacity at its facility ...
MilliporeSigma, Merck KGaA’s North American subsidiary, opened the doors to its $65 million high-potency active pharmaceutical ingredient (HPAPI) manufacturing facility with a focus on cancer ...
BURLINGTON, Mass., Sept. 26, 2023 /PRNewswire/ -- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO (contract testing, development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results